Sign inJoin
Company / Finance

Ascent Industries Co.

ACNT · NASDAQ

Ascent Industries is trying to turn a cash-rich post-divestiture shell into a focused specialty chemicals platform, with Q1 revenue growth, no revolver debt, aggressive buybacks, a Midwest packaging-chemistry acquisition, and unresolved proof gates around margins, customer concentration, and controls.

FollowAdd to WatchlistAsk Question
NASDAQACNTCoverage BootstrapSpecialty ChemicalsTurnaroundIndustrial
Latest ReportMay 13, 2026ACNT: the chemicals turnaround that sold the pipe business and bought packaging chemistryView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 of 1 reports match
Clear filters
Selected tags
Specialty ChemicalsACNT
Clear tags
MatchAny tagAll tags
Latest Thesis

ACNT: the chemicals turnaround that sold the pipe business and bought packaging chemistry

Ascent Industries is trying to turn a cash-rich post-divestiture shell into a focused specialty chemicals platform, with Q1 revenue growth, no revolver debt, aggressive buybacks, a Midwest packaging-chemistry acquisition, and unresolved proof gates around margins, customer concentration, and controls.

May 13, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
Ascent Industries Co.the chemicals turnaround that sold the pipe business and bought May 13, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
ACNT: the chemicals turnaround that sold the pipe business and bought packaging chemistryAscent Industries is trying to turn a cash-rich post-divestiture shell into a focused specialty chemicals platform, with Q1 revenue growth, no revolver debt, aggressive buybacks, a Midwest packaging-chemistry acquisition, and unresolved proof gates around margins, customer concentration, and controls.NASDAQMay 13, 2026Research reportReadSlides